Ocugen (OCGN) Tax Provisions (2021)
Ocugen posted quarterly Tax Provisions of -$52000.0 for Q3 2021.
Ocugen (OCGN) has 1 years of Tax Provisions data on file, last reported at -$52000.0 in Q3 2021.
- For the quarter ending Q3 2021, Tax Provisions changed N/A year-over-year to -$52000.0; the trailing twelve-month figure through Dec 2022 stood at -$52000.0 (changed 0.0% YoY), and the FY2021 full-year result was -$52000.0, changed N/A from the prior year.
- Tax Provisions for Q3 2021 stood at -$52000.0.
- Across five years, Tax Provisions topped out at -$52000.0 in Q3 2021 and bottomed at -$52000.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -52,000.00 |